Artificial intelligence is revolutionizing life science R&D (particularly in the realm of drug discovery) and challenging the traditional "human inventorship" requirement for U.S. patents. Recent guidance from the USPTO...more
4/9/2025
/ Artificial Intelligence ,
Drug Pricing ,
Earn-Outs ,
Federal Funding ,
Foreign Aid ,
Healthcare ,
Inflation Reduction Act (IRA) ,
Intellectual Property Protection ,
Inventions ,
Inventors ,
Life Sciences ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Private Equity ,
Trump Administration ,
USPTO
In 2024, Delaware courts issued multiple instructive decisions on earnout provisions in life sciences M&A transactions. ...more
4/3/2025
/ Acquisition Agreements ,
Breach of Contract ,
Business Disputes ,
Buyers ,
Commercial Litigation ,
Commercially Reasonable Efforts ,
Corporate Sales Transactions ,
Delaware ,
Dispute Resolution ,
Earn-Outs ,
Life Sciences ,
Merger Agreements ,
Pharmaceutical Industry ,
Purchase Agreement ,
Sellers ,
Selling a Business